Novel strategies in diastolic heart failure

Heart

Volumn 96, Issue 14, 2010, Pages 1147-1153

  Paulus, Walter J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; CANDESARTAN; CARVEDILOL; CHLORTALIDONE; DIGOXIN; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; ISOSORBIDE DINITRATE; LISINOPRIL; LOSARTAN; NEBIVOLOL; PERINDOPRIL; PLACEBO; PROPRANOLOL; RAMIPRIL;

CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIASTOLIC HEART FAILURE; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; PRIORITY JOURNAL; REVIEW; TISSUE DOPPLER IMAGING;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; HEART FAILURE, DIASTOLIC; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77954442660     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2009.169052     Document Type: Review

References (20)

1. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure? A consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction (HFNEF) by the Heart Failure and Echocardiography Associations of the European society of cardiology. Eur Heart J 2007;28:2539-50. Consensus document providing useful flowcharts for diagnosis and exclusion of DHF.
2. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9. Important epidemiological study revealing high prevalence of DHF up to 55% among community heart failure patients and failure over the last decade to improve prognosis in DHF with current heart failure treatment.
3. Persson H, Lonn E, Edner M, et al. Investigators of the CHARM echocardiographic substudy - CHARMES. J Am Coll Cardiol 2007;49:687-94.
4. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur Heart J 1998;19:990-1003.
5. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
6. Oh JK, Hatle L, Tajik AJ, et al. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2006;47:500-6. (Pubitemid 43170836)
7. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-33. Consensus document providing a strategy for echocardiographic evaluation of diastolic LV dysfunction in heart failure with normal and reduced LVEF.
8. Little WC, Oh JK. Echocardiographic evaluation of diastolic function can be used to guide clinical care. Circulation 2009;120:802-809. Pro side of 'controversies in cardiovascular medicine' evaluating echocardiographic evaluation of diastolic LV function.
9. Tschöpe C, Paulus WJ. Doppler echocardiography yields dubious estimates of left ventricular diastolic pressures. Circulation 2009;120:810-820 Con side of 'controversies in cardiovascular medicine' evaluating echocardiographic evaluation of diastolic LV function.
10. Granger CB, McMurray JJ, Yusuf S, et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensinconverting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003;362:772-6.
11. Massie BM, Carson PE, McMurray JJ, et al. I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008;359:2456-67. Largest DHF trial reported so far showing a neutral outcome of irbesartan.
12. Little WC. Hypertension, heart failure and ejection fraction. Circulation 2008;118:2223-4.
13. van Heerebeek L, Borbély A, Niessen HW, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006;113:1966-73. The first study to compare myocardial histology and contractile function of isolated cardiomyocytes between DHF and SHF.
14. Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006;27:2338-45. First major randomised controlled trial on the use of ACEIs in DHF patients
15. Davis BR, Kostis JB, Simpson LM, et al; for the ALLHAT Collaborative Research Group. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation 2008;118:2259-67.
16. van Veldhuisen DJ, Cohen-Solal A, Böhm M, et al; SENIORS Investigators. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol. 2009;53:2150-8.
17. Mottram PM, Haluska B, Leano R, et al. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 2004;110:558-65. (Pubitemid 39031173)
18. Ahmed A, Rich MW, Fleg JL, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the Ancillary Digitalis Investigation Group trial. Circulation 2006;114:397-403. (Pubitemid 44264821)
19. Fukata H, Sane DC, Brucks S, et al. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 2005;112:357-63.
20. Paulus WJ, van Ballegoij JJM. Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 2010;55:526-537. In-depth overview of current and future DHF treatment.